Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of RF, and Anti-CCP on RA Patients in Response to Etanercept

NCT04428424 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04428424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04428424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of RF, and Anti-CCP on RA Patients in Response to Etanercept
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 5, 2020
Completion date
August 30, 2020
Enrollment
1,493 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid